Carmichael Hill & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDS
ACA
CAI
CIA
MMA
RJFSA
Carmichael Hill & Associates's IBDS Position: Q2 2023 in Review
Carmichael Hill & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2023, closing a stake of 571 shares — an estimated $13.6K sold.
Carmichael Hill & Associates first reported a position in IBDS in Q3 2022 and held it in 3 quarters. The position peaked at $13.6K in Q1 2023. 183 funds tracked by Wall St. Rank hold IBDS as of Q2 2023.
- Carmichael Hill & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q2 2023 after selling out during the quarter.
- Carmichael Hill & Associates sold 571 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2023, an estimated $13.6K.
- Carmichael Hill & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2022 and held it in 3 quarters.
- Carmichael Hill & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $13.6K in Q1 2023.
- 183 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2023.
Based on Carmichael Hill & Associates's 13F filing for Q2 2023, filed 4 Aug 2023.